Stonebridge Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,115
| Closed | -$222K | – | 99 |
|
|
2022
Q2 | $222K | Hold |
2,115
| – | – | 0.1% | 92 |
|
|
2022
Q1 | $271K | Sell |
2,115
-63
| -3% | -$7.59K | 0.1% | 89 |
|
|
2021
Q4 | $269K | Hold |
2,178
| – | – | 0.09% | 93 |
|
|
2021
Q3 | $310K | Hold |
2,178
| – | – | 0.11% | 87 |
|
|
2021
Q2 | $340K | Sell |
2,178
-155
| -7% | -$25.1K | 0.12% | 81 |
|
|
2021
Q1 | $363K | Hold |
2,333
| – | – | 0.14% | 77 |
|
|
2020
Q4 | $349K | Hold |
2,333
| – | – | 0.14% | 75 |
|
|
2020
Q3 | $308K | Hold |
2,333
| – | – | 0.14% | 76 |
|
|
2020
Q2 | $270K | Hold |
2,333
| – | – | 0.14% | 81 |
|
|
2020
Q1 | $229K | Hold |
2,333
| – | – | 0.13% | 88 |
|
|
2019
Q4 | $339K | Hold |
2,333
| – | – | 0.15% | 82 |
|
|
2019
Q3 | $311K | Sell |
2,333
-309
| -12% | -$39.9K | 0.14% | 84 |
|
|
2019
Q2 | $302K | Hold |
2,642
| – | – | 0.12% | 95 |
|
|
2019
Q1 | $327K | Hold |
2,642
| – | – | 0.12% | 106 |
|
|
2018
Q4 | $266K | Hold |
2,642
| – | – | 0.11% | 107 |
|
|
2018
Q3 | $337K | Hold |
2,642
| – | – | 0.12% | 100 |
|
|
2018
Q2 | $290K | Sell |
2,642
-515
| -16% | -$56K | 0.1% | 103 |
|
|
2018
Q1 | $324K | Hold |
3,157
| – | – | 0.12% | 101 |
|
|
2017
Q4 | $375K | Sell |
3,157
-1,592
| -34% | -$180K | 0.13% | 98 |
|
|
2017
Q3 | $540K | Hold |
4,749
| – | – | 0.2% | 78 |
|
|
2017
Q2 | $593K | Hold |
4,749
| – | – | 0.23% | 74 |
|
|
2017
Q1 | $563K | Sell |
4,749
-206
| -4% | -$23.3K | 0.23% | 73 |
|
|
2016
Q4 | $496K | Hold |
4,955
| – | – | 0.21% | 76 |
|
|
2016
Q3 | $625K | Hold |
4,955
| – | – | 0.27% | 63 |
|
|
2016
Q2 | $580K | Hold |
4,955
| – | – | 0.26% | 63 |
|
|
2016
Q1 | $513K | Sell |
4,955
-52
| -1% | -$5.03K | 0.22% | 77 |
|
|
2015
Q4 | $499K | Hold |
5,007
| – | – | 0.21% | 88 |
|
|
2015
Q3 | $457K | Hold |
5,007
| – | – | 0.21% | 93 |
|
|
2015
Q2 | $531K | Hold |
5,007
| – | – | 0.22% | 93 |
|
|
2015
Q1 | $571K | Hold |
5,007
| – | – | 0.23% | 89 |
|
|
2014
Q4 | $552K | Hold |
5,007
| – | – | 0.21% | 94 |
|
|
2014
Q3 | $488K | Hold |
5,007
| – | – | 0.19% | 108 |
|
|
2014
Q2 | $505K | Hold |
5,007
| – | – | 0.19% | 108 |
|
|
2014
Q1 | $460K | Hold |
5,007
| – | – | 0.19% | 112 |
|
|
2013
Q4 | $453K | Hold |
5,007
| – | – | 0.18% | 114 |
|
|
2013
Q3 | $399K | Hold |
5,007
| – | – | 0.18% | 121 |
|
|
2013
Q2 | $364K | Buy |
+5,007
| New | +$374K | 0.17% | 122 |
|
Other funds holding ZBH
Stonebridge Capital Management's ZBH Position: Q3 2022 in Review
Stonebridge Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 2,115 shares — an estimated $222K sold.
Stonebridge Capital Management first reported a position in ZBH in Q2 2013 and held it in 37 quarters. The position peaked at $625K in Q3 2016. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.
- Stonebridge Capital Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
- Stonebridge Capital Management sold 2,115 Zimmer Biomet shares in Q3 2022, an estimated $222K.
- Stonebridge Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 37 quarters.
- Stonebridge Capital Management's Zimmer Biomet position peaked at $625K in Q3 2016.
- 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.
Based on Stonebridge Capital Management's 13F filing for Q3 2022, filed 6 Oct 2022.